Nikolaos Shinas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nikolaos Shinas has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Vasileios Zisis
Department of Oral Medicine and Pathology, School of Dentistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
6 shared publications - Athanasios Poulopoulos
Department of Oral Medicine and Pathology, School of Dentistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
4 shared publications - Christina Charisi
Department of Oral Medicine and Pathology, School of Dentistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
3 shared publications - Konstantinos Poulopoulos
Department of Dentoalveolar Surgery, Surgical Implantology and Radiology, School of Dentistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
3 shared publications - Deeba Kashtwari
Department of Oral and Maxillofacial Radiology, Henry M. Goldman School of Dental Medicine, Boston University, Boston, USA
2 shared publications - Dhurata Shosho
Department of Oral and Maxillofacial Radiology, Henry M. Goldman School of Dental Medicine, Boston University, Boston, USA
2 shared publications
Latest Publications
- Open Access
Adjunctive Antimicrobial Therapy in Peri-Implant Diseases: A Narrative Review
Background: Effective management of peri-implant disease relies primarily on mechanical removal of the bacterial biofilm. However, achieving adequate surface decontamination can be challenging due to complex implant-surface morphology and restricted access to deep peri-implant pockets. This has prompted the use of adjunctive antimicrobial agents to complement mechanical therapy and improve therapeutic outcomes. Objective: To investigate whether the adjunctive use of antimicrobial strategies improves clinical, microbiological, and radiographic outcomes in patients with peri-implant mucositis and peri-implantitis. Materials and Methods: A structured narrative review was conducted using PubMed/MEDLINE and Scopus in July 2026. No database filters concerning language, human participants or study design were applied. During the screening process, only randomized controlled clinical trials involving human participants and available as English-language full texts were selected. Eligible interventions included locally or systemically administered antibiotics, antiseptics, antimicrobial drug-delivery systems, antimicrobial photodynamic therapy (aPDT), ozone-based therapies, and microbiome-modulating adjuncts. Conventional laser therapy was not classified as an eligible antimicrobial intervention. The database searches retrieved 462 records, including 252 from PubMed and 210 from Scopus. Following duplicate removal and eligibility assessment, 100 publications representing 93 independent clinical trials were included. Results: adjunctive antimicrobial efficacy was highly variable and appeared to depend on disease severity, debridement strategy, antimicrobial agent, delivery modality, and follow-up period. Repeated or sustained local antimicrobial delivery was associated with modest, short-term benefits in several studies, whereas chlorhexidine (CHX) generally provided limited additional benefit over mechanical therapy. Evidence for systemic antibiotics remained inconsistent and insufficient to support routine use, while aPDT offered potential benefits that varied according to treatment protocol. Ozone therapy, herbal agents, and novel drug-delivery systems yielded encouraging preliminary results, although evidence remains scarce. Moreover, reductions in bleeding and probing depth (PD) did not reliably correspond to superior microbiological outcomes, radiographic bone gain, or complete disease resolution. Conclusions: Mechanical debridement (MD) and effective plaque control remain central to peri-implant disease management. Some adjunctive interventions produced modest short-term improvements in individual studies; however, the available evidence does not demonstrate durable disease control or support routine use. Therapeutic decisions should be tailored to disease severity, patient and implant characteristics, and the balance between potential benefits and antimicrobial-associated risks. Further well-designed and adequately powered randomized controlled trials with extended follow-up periods are needed to establish more definitive recommendations.
Open AccessAdjunctive Antimicrobial Therapy in Peri-Implant Diseases: A Narrative Review
Background: Effective management of peri-implant disease relies primarily on mechanical removal of the bacterial biofilm. However, achieving adequate surface decontamination can be challenging due to complex implant-surface morphology and restricted access to deep peri-implant pockets. This has prompted the use of adjunctive antimicrobial agents to complement mechanical therapy and improve therapeutic outcomes. Objective: To investigate whether the adjunctive use of antimicrobial strategies improves clinical, microbiological, and radiographic outcomes in patients with peri-implant mucositis and peri-implantitis. Materials and Methods: A structured narrative review was conducted using PubMed/MEDLINE and Scopus in July 2026. No database filters concerning language, human participants or study design were applied. During the screening process, only randomized controlled clinical trials involving human participants and available as English-language full texts were selected. Eligible interventions included locally or systemically administered antibiotics, antiseptics, antimicrobial drug-delivery systems, antimicrobial photodynamic therapy (aPDT), ozone-based therapies, and microbiome-modulating adjuncts. Conventional laser therapy was not classified as an eligible antimicrobial intervention. The database searches retrieved 462 records, including 252 from PubMed and 210 from Scopus. Following duplicate removal and eligibility assessment, 100 publications representing 93 independent clinical trials were included. Results: adjunctive antimicrobial efficacy was highly variable and appeared to depend on disease severity, debridement strategy, antimicrobial agent, delivery modality, and follow-up period. Repeated or sustained local antimicrobial delivery was associated with modest, short-term benefits in several studies, whereas chlorhexidine (CHX) generally provided limited additional benefit over mechanical therapy. Evidence for systemic antibiotics remained inconsistent and insufficient to support routine use, while aPDT offered potential benefits that varied according to treatment protocol. Ozone therapy, herbal agents, and novel drug-delivery systems yielded encouraging preliminary results, although evidence remains scarce. Moreover, reductions in bleeding and probing depth (PD) did not reliably correspond to superior microbiological outcomes, radiographic bone gain, or complete disease resolution. Conclusions: Mechanical debridement (MD) and effective plaque control remain central to peri-implant disease management. Some adjunctive interventions produced modest short-term improvements in individual studies; however, the available evidence does not demonstrate durable disease control or support routine use. Therapeutic decisions should be tailored to disease severity, patient and implant characteristics, and the balance between potential benefits and antimicrobial-associated risks. Further well-designed and adequately powered randomized controlled trials with extended follow-up periods are needed to establish more definitive recommendations.
- Open Access
N6-Methyladenosine (m6A) RNA Modification in Periodontitis: Molecular Mechanisms and Therapeutic Potential: A Narrative Review
Background: N6-methyladenosine (m6A) is the most abundant mRNA internal modification in eukaryotes and regulates inflammatory and regenerative processes. Many studies relate the dysregulation of m6A-related pathways to periodontal inflammation, imbalance in cell homeostasis, impaired tissue regeneration, and remodeling of the alveolar bone. However, the mechanisms of the relationship between the m6A pathway and periodontitis have not been elucidated clearly yet. Objective: The objective of the current narrative review is to integrate the information related to the role of m6A RNA modification in the pathogenesis of periodontitis by focusing on inflammatory signaling, osteoimmune regulation, periodontal cell activity, bone remodeling, and its possible applications as a diagnosis and treatment approach. Methods: A literature search was conducted in PubMed to identify original research studies investigating the role of m6A RNA methylation and its regulators in periodontitis and periodontal tissues/cells. Out of 49 publications reviewed, 34 original research articles fulfilled the predetermined inclusion criteria. Results: The current literature suggests that N6-methyladenosine (m6A) modification is involved in various interconnected biological processes contributing to the development of periodontitis, including inflammatory responses, inflammasome activation and pyroptosis, osteoimmune reactions by macrophages, osteogenic differentiation, osteoclast formation, cellular senescence, and periodontal cells homeostasis. METTL3 has been reported to be the most widely investigated regulator, but its roles are not consistently harmful or beneficial. Depending on the RNA target, cellular environment, and state of inflammation, some of the m6A-associated pathways have been linked to periodontal inflammation and alveolar bone resorption, while others were linked to osteogenesis and regeneration. Several studies have highlighted the possibility of therapeutic interference in pathways leading to the formation of m6A, while human transcriptomic and gingival/salivary studies suggested that m6A could be used as a biomarker. Conclusions: The m6A modification of RNA is an emerging epitranscriptomic effect relating periodontal inflammation, immune responses, cellular differentiation, and bone remodeling. Even though target molecules and signaling pathways have been experimentally identified as points of potential therapeutic interference, the available evidence remains predominantly preclinical. Future work is expected to validate the diagnostic and therapeutic involvement of the m6A modification in periodontitis.
Open AccessN6-Methyladenosine (m6A) RNA Modification in Periodontitis: Molecular Mechanisms and Therapeutic Potential: A Narrative Review
Background: N6-methyladenosine (m6A) is the most abundant mRNA internal modification in eukaryotes and regulates inflammatory and regenerative processes. Many studies relate the dysregulation of m6A-related pathways to periodontal inflammation, imbalance in cell homeostasis, impaired tissue regeneration, and remodeling of the alveolar bone. However, the mechanisms of the relationship between the m6A pathway and periodontitis have not been elucidated clearly yet. Objective: The objective of the current narrative review is to integrate the information related to the role of m6A RNA modification in the pathogenesis of periodontitis by focusing on inflammatory signaling, osteoimmune regulation, periodontal cell activity, bone remodeling, and its possible applications as a diagnosis and treatment approach. Methods: A literature search was conducted in PubMed to identify original research studies investigating the role of m6A RNA methylation and its regulators in periodontitis and periodontal tissues/cells. Out of 49 publications reviewed, 34 original research articles fulfilled the predetermined inclusion criteria. Results: The current literature suggests that N6-methyladenosine (m6A) modification is involved in various interconnected biological processes contributing to the development of periodontitis, including inflammatory responses, inflammasome activation and pyroptosis, osteoimmune reactions by macrophages, osteogenic differentiation, osteoclast formation, cellular senescence, and periodontal cells homeostasis. METTL3 has been reported to be the most widely investigated regulator, but its roles are not consistently harmful or beneficial. Depending on the RNA target, cellular environment, and state of inflammation, some of the m6A-associated pathways have been linked to periodontal inflammation and alveolar bone resorption, while others were linked to osteogenesis and regeneration. Several studies have highlighted the possibility of therapeutic interference in pathways leading to the formation of m6A, while human transcriptomic and gingival/salivary studies suggested that m6A could be used as a biomarker. Conclusions: The m6A modification of RNA is an emerging epitranscriptomic effect relating periodontal inflammation, immune responses, cellular differentiation, and bone remodeling. Even though target molecules and signaling pathways have been experimentally identified as points of potential therapeutic interference, the available evidence remains predominantly preclinical. Future work is expected to validate the diagnostic and therapeutic involvement of the m6A modification in periodontitis.
- 14 August 2026
- Published by Springer Nature in Oral Radiology
- Vol. 42 (4) , 1316-1322
Gonadotroph neuroendocrine tumor of the pituitary gland (PitNET): a rare incidental finding on CBCT
- 14 August 2026
- Published by Springer Nature in Oral Radiology
- Vol. 42 (4) , 1316-1322
Gonadotroph neuroendocrine tumor of the pituitary gland (PitNET): a rare incidental finding on CBCT
- Open Access
Rheumatoid Arthritis and Periodontitis: Shared Pathogenic Mechanisms and Clinical Implications: A Narrative Review
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by systemic inflammation, synovial hyperplasia, and progressive joint destruction. Periodontitis, a chronic inflammatory disease affecting the supporting structures of teeth, has been increasingly recognized as a potential contributor to RA pathogenesis. Evidence suggests that both conditions share common immunological mechanisms and microbial triggers. This review summarizes the data linking RA with periodontitis, with particular focus on shared pathogenic pathways, microbial triggers, immune system alterations, and clinical relevance. Methods: Experimental, epidemiological, and clinical studies were evaluated to explore biological and clinical links between periodontitis and RA. Special emphasis was placed on the mucosal origins of RA, bacterial-mediated citrullination, autoantibody formation, and the role of the complement system. Results: Available epidemiological data indicate that individuals with RA present higher prevalence and greater severity of periodontitis. Periodontal pathogens, such as Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans, contribute to immune dysregulation through citrullination, and subsequent production of anti-citrullinated protein antibodies (ACPAs), a hallmark of RA. Both diseases are characterized by chronic, uncontrolled inflammation, amplified by complement activation and neutrophil hyperactivity. Clinical evidence suggests that non-surgical periodontal therapy may reduce systemic inflammatory markers and improve RA disease activity. Conclusions: The relationship between RA and periodontitis appears to be bidirectional and the recognition of this interaction supports closer collaboration between rheumatologists and dental professionals. Future studies are required to clarify causality and determine whether management strategies can influence patient outcomes.
Open AccessRheumatoid Arthritis and Periodontitis: Shared Pathogenic Mechanisms and Clinical Implications: A Narrative Review
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by systemic inflammation, synovial hyperplasia, and progressive joint destruction. Periodontitis, a chronic inflammatory disease affecting the supporting structures of teeth, has been increasingly recognized as a potential contributor to RA pathogenesis. Evidence suggests that both conditions share common immunological mechanisms and microbial triggers. This review summarizes the data linking RA with periodontitis, with particular focus on shared pathogenic pathways, microbial triggers, immune system alterations, and clinical relevance. Methods: Experimental, epidemiological, and clinical studies were evaluated to explore biological and clinical links between periodontitis and RA. Special emphasis was placed on the mucosal origins of RA, bacterial-mediated citrullination, autoantibody formation, and the role of the complement system. Results: Available epidemiological data indicate that individuals with RA present higher prevalence and greater severity of periodontitis. Periodontal pathogens, such as Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans, contribute to immune dysregulation through citrullination, and subsequent production of anti-citrullinated protein antibodies (ACPAs), a hallmark of RA. Both diseases are characterized by chronic, uncontrolled inflammation, amplified by complement activation and neutrophil hyperactivity. Clinical evidence suggests that non-surgical periodontal therapy may reduce systemic inflammatory markers and improve RA disease activity. Conclusions: The relationship between RA and periodontitis appears to be bidirectional and the recognition of this interaction supports closer collaboration between rheumatologists and dental professionals. Future studies are required to clarify causality and determine whether management strategies can influence patient outcomes.
- Open Access
- 19 February 2026
- Published by Springer Nature in Journal of Imaging Informatics in Medicine
Development of a 3D Convolutional Neural Network for the Triage of High-Priority Oral and Maxillofacial CBCT Scans
This project aims to establish a triage system for oral and maxillofacial cone-beam computed tomography (CBCT) scans by developing a neural network to identify high-priority cases. Two hundred scans and reports were reviewed to form two cohorts: Group A included 100 patients with significant oral and maxillofacial findings in the oral and maxillofacial region, and Group B included 100 patients without major findings. Scans with only minor abnormalities were assigned to Group B. CBCT images from the groups were merged and split into training (70%) and validation (30%) sets. Two 3D convolutional neural network (3D-CNN) models were developed using Python and Keras: Model 1, inspired by Zunair et al., and Model 2, based on a modified VGG-16 architecture. Data augmentation, the Adam optimizer, and early stopping were applied during training. Each model was trained five times with randomized dataset shuffling, and performance was evaluated using ROC-AUC, accuracy, precision, recall, and F1-score. A Welch’s t -test was used to compare model performance. Both models had excellent performance with Model 2 achieving a slightly higher mean ROC-AUC of 0.918 on validation with no statistically significant inter-model performance ( p = 0.078). Model 2 featured advanced architecture with four convolutional blocks and dense layers, optimizing accuracy (0.960) and precision (0.962) in training. In this study, we successfully developed an accurate 3D-CNN based on CBCT images to distinguish between high-priority scans and routine reports. To the best of our knowledge, this is the first study to address this specific task.
- 19 February 2026
- Published by Springer Nature in Journal of Imaging Informatics in Medicine
Open AccessDevelopment of a 3D Convolutional Neural Network for the Triage of High-Priority Oral and Maxillofacial CBCT Scans
This project aims to establish a triage system for oral and maxillofacial cone-beam computed tomography (CBCT) scans by developing a neural network to identify high-priority cases. Two hundred scans and reports were reviewed to form two cohorts: Group A included 100 patients with significant oral and maxillofacial findings in the oral and maxillofacial region, and Group B included 100 patients without major findings. Scans with only minor abnormalities were assigned to Group B. CBCT images from the groups were merged and split into training (70%) and validation (30%) sets. Two 3D convolutional neural network (3D-CNN) models were developed using Python and Keras: Model 1, inspired by Zunair et al., and Model 2, based on a modified VGG-16 architecture. Data augmentation, the Adam optimizer, and early stopping were applied during training. Each model was trained five times with randomized dataset shuffling, and performance was evaluated using ROC-AUC, accuracy, precision, recall, and F1-score. A Welch’s t -test was used to compare model performance. Both models had excellent performance with Model 2 achieving a slightly higher mean ROC-AUC of 0.918 on validation with no statistically significant inter-model performance ( p = 0.078). Model 2 featured advanced architecture with four convolutional blocks and dense layers, optimizing accuracy (0.960) and precision (0.962) in training. In this study, we successfully developed an accurate 3D-CNN based on CBCT images to distinguish between high-priority scans and routine reports. To the best of our knowledge, this is the first study to address this specific task.
- Open Access
- 1 January 2026
- Published by Medicina Oral, S.L. in Journal of Clinical and Experimental Dentistry
- Vol. 18 (4) , e534-e548
The effects of different implant crown restorative materials on the detection of proximal caries of adjacent teeth in cone-beam computed tomography (CBCT) scans using various machines, metal artifact-reduction (MAR) algorithm, and exposure protocols
This study aimed to investigate how artifacts from different restorative materials affect the detection of approximal caries in CBCT scans, using various machines, artifact-reduction (AR) algorithms, and exposure protocols. Ten permanent teeth (5 molars, 5 premolars) were selected and categorized into 3 intact and 7 with artificial carious lesions. The teeth were arranged in a human mandible with an ingot of material in-between and in the following approximal surfaces configurations: intact-ingot-intact, caries-ingot-caries, and intact-ingot-caries/caries-ingot-intact. Three different ingot materials were used (3Y and 5Y Zirconia, and E-Max) and the setup was scanned using two CBCT systems (Planmeca Mid and Prexion) with varying exposure protocols, with and without AR algorithm, thus resulting in 90 scans. Three observers of different experience levels evaluated the images and P and Kappa values were calculated. Kappa and P values showed a significant positive association with the AR option, and a negative association without AR for zirconia 5Y. Zirconia 3Y had the highest positive association across all observers using both low and standard exposure settings on the Prexion®. The inter-observer agreement was insignificant, while intra-observer agreement was highly significant. The AR option improves the accuracy of approximal caries detection in CBCT scans for materials with higher yttria concentration but has no significant effect on lower yttria materials. The Prexion® scanner outperformed the Planmeca ProMax 3D Mid® in caries detection without AR.
- 1 January 2026
- Published by Medicina Oral, S.L. in Journal of Clinical and Experimental Dentistry
- Vol. 18 (4) , e534-e548
Open AccessThe effects of different implant crown restorative materials on the detection of proximal caries of adjacent teeth in cone-beam computed tomography (CBCT) scans using various machines, metal artifact-reduction (MAR) algorithm, and exposure protocols
This study aimed to investigate how artifacts from different restorative materials affect the detection of approximal caries in CBCT scans, using various machines, artifact-reduction (AR) algorithms, and exposure protocols. Ten permanent teeth (5 molars, 5 premolars) were selected and categorized into 3 intact and 7 with artificial carious lesions. The teeth were arranged in a human mandible with an ingot of material in-between and in the following approximal surfaces configurations: intact-ingot-intact, caries-ingot-caries, and intact-ingot-caries/caries-ingot-intact. Three different ingot materials were used (3Y and 5Y Zirconia, and E-Max) and the setup was scanned using two CBCT systems (Planmeca Mid and Prexion) with varying exposure protocols, with and without AR algorithm, thus resulting in 90 scans. Three observers of different experience levels evaluated the images and P and Kappa values were calculated. Kappa and P values showed a significant positive association with the AR option, and a negative association without AR for zirconia 5Y. Zirconia 3Y had the highest positive association across all observers using both low and standard exposure settings on the Prexion®. The inter-observer agreement was insignificant, while intra-observer agreement was highly significant. The AR option improves the accuracy of approximal caries detection in CBCT scans for materials with higher yttria concentration but has no significant effect on lower yttria materials. The Prexion® scanner outperformed the Planmeca ProMax 3D Mid® in caries detection without AR.
- Open Access
Current Insights on Salivary Gland Adenoid Cystic Carcinoma: Related Genes and Molecular Pathways
Background/Objectives: Salivary adenoid cystic carcinoma (ACC) is a rare but aggressive neoplasm that predominantly arises from the salivary glands, accounting for a significant proportion of salivary gland cancers. The aim of this literature review is to illustrate the current insights on ACC with regards to related genes and molecular pathways by analyzing original research articles from the period 2015–2025. Methods: An electronic search of literature was performed between January and February 2025 to identify all articles investigating the current insights on salivary gland adenoid cystic carcinoma and its related genes and molecular pathways. The search was conducted using MEDLINE (National Library of Medicine)-PubMed with restrictions concerning the date of publication. In particular, we focused on the period 2015–2025 using the following keywords: Salivary gland adenoid cystic carcinoma AND genes AND molecular pathways. This was followed by a manual search, and references were used to identify relevant articles. Results: In total, 41 articles were identified through the keywords. After the implementation of the time frame 2015–2025, 31 articles remained. Subsequently, by reading the titles and abstracts and thereby excluding non-original research articles and articles written in a language other than English, 23 articles remained. Conclusions: These studies identified 23 relevant genes or pathways whose analysis yielded the most recent data regarding their function. The classification of ACC is multifaceted, encompassing distinct histological subtypes that are crucial for determining prognosis and treatment approaches. Current oncological practices classify ACC based on these histological features alongside emerging genetic and molecular markers that promise to enhance our understanding of the disease’s biology. Diagnostic strategies have evolved, leveraging techniques such as biopsy and molecular diagnostics, which have significantly improved the detection and characterization of ACC. Regarding treatment, the management of ACC remains a challenge due to its propensity for local invasion and metastasis, with surgery, radiation, and chemotherapy being the mainstays of therapy. The development of targeted therapies based on ACC’s molecular profile will allow for a better prognosis and an enhanced quality of life of patients.
Open AccessCurrent Insights on Salivary Gland Adenoid Cystic Carcinoma: Related Genes and Molecular Pathways
Background/Objectives: Salivary adenoid cystic carcinoma (ACC) is a rare but aggressive neoplasm that predominantly arises from the salivary glands, accounting for a significant proportion of salivary gland cancers. The aim of this literature review is to illustrate the current insights on ACC with regards to related genes and molecular pathways by analyzing original research articles from the period 2015–2025. Methods: An electronic search of literature was performed between January and February 2025 to identify all articles investigating the current insights on salivary gland adenoid cystic carcinoma and its related genes and molecular pathways. The search was conducted using MEDLINE (National Library of Medicine)-PubMed with restrictions concerning the date of publication. In particular, we focused on the period 2015–2025 using the following keywords: Salivary gland adenoid cystic carcinoma AND genes AND molecular pathways. This was followed by a manual search, and references were used to identify relevant articles. Results: In total, 41 articles were identified through the keywords. After the implementation of the time frame 2015–2025, 31 articles remained. Subsequently, by reading the titles and abstracts and thereby excluding non-original research articles and articles written in a language other than English, 23 articles remained. Conclusions: These studies identified 23 relevant genes or pathways whose analysis yielded the most recent data regarding their function. The classification of ACC is multifaceted, encompassing distinct histological subtypes that are crucial for determining prognosis and treatment approaches. Current oncological practices classify ACC based on these histological features alongside emerging genetic and molecular markers that promise to enhance our understanding of the disease’s biology. Diagnostic strategies have evolved, leveraging techniques such as biopsy and molecular diagnostics, which have significantly improved the detection and characterization of ACC. Regarding treatment, the management of ACC remains a challenge due to its propensity for local invasion and metastasis, with surgery, radiation, and chemotherapy being the mainstays of therapy. The development of targeted therapies based on ACC’s molecular profile will allow for a better prognosis and an enhanced quality of life of patients.
- Open Access
Mural Unicystic Ameloblastoma of the Mandible: A Case Report
Background and Clinical Significance: Among the odontogenic tumors, ameloblastoma is one of the most notorious, although it remains relatively rare, accounting for approximately one percent of all oral tumors. This neoplasm, derived from odontogenic epithelium, may arise from the developing enamel organ, epithelial cell rests of dental lamina, epithelial lining of odontogenic cysts, and basal cells of oral epithelium. This is a case presentation of a mural unicystic ameloblastoma, the most aggressive subtype and the one with the highest chance of recurrence. Case Presentation: A patient was referred by his dentist for root canal treatment at the Emergency Dental Clinic of Boston University. The patient complained of mandibular numbness. A panoramic radiograph was acquired, revealing a radiolucent lesion in the right mandible. Clinical examination detected a soft swelling perforating the buccal cortex in the area of #27–#30. A Cone-Beam CT (CBCT) was acquired in the Oral and Maxillofacial Radiology Clinic revealing a well-defined, partially corticated entity in the periapical area of teeth #27 through #30, with evidence of scalloping borders. The internal structure was unilocular and uniformly low-density. The entity caused interruption of the lamina dura of the associated teeth and inferior displacement of the inferior alveolar canal. Differential diagnoses included unicystic ameloblastoma (UA) and central giant cell granuloma as a second less likely diagnosis. An incisional biopsy was performed for further evaluation. Biopsy confirmed UA with mural involvement. Conclusions: UAs typically exhibit less aggressive behavior. However, cases like this one, where mural involvement is noted and no associated impaction is detected, underline the possibility of variable radiographic presentation and the significance of a multidisciplinary approach in correct diagnosis and treatment. Histological subtyping is crucial for guiding treatment.
Open AccessMural Unicystic Ameloblastoma of the Mandible: A Case Report
Background and Clinical Significance: Among the odontogenic tumors, ameloblastoma is one of the most notorious, although it remains relatively rare, accounting for approximately one percent of all oral tumors. This neoplasm, derived from odontogenic epithelium, may arise from the developing enamel organ, epithelial cell rests of dental lamina, epithelial lining of odontogenic cysts, and basal cells of oral epithelium. This is a case presentation of a mural unicystic ameloblastoma, the most aggressive subtype and the one with the highest chance of recurrence. Case Presentation: A patient was referred by his dentist for root canal treatment at the Emergency Dental Clinic of Boston University. The patient complained of mandibular numbness. A panoramic radiograph was acquired, revealing a radiolucent lesion in the right mandible. Clinical examination detected a soft swelling perforating the buccal cortex in the area of #27–#30. A Cone-Beam CT (CBCT) was acquired in the Oral and Maxillofacial Radiology Clinic revealing a well-defined, partially corticated entity in the periapical area of teeth #27 through #30, with evidence of scalloping borders. The internal structure was unilocular and uniformly low-density. The entity caused interruption of the lamina dura of the associated teeth and inferior displacement of the inferior alveolar canal. Differential diagnoses included unicystic ameloblastoma (UA) and central giant cell granuloma as a second less likely diagnosis. An incisional biopsy was performed for further evaluation. Biopsy confirmed UA with mural involvement. Conclusions: UAs typically exhibit less aggressive behavior. However, cases like this one, where mural involvement is noted and no associated impaction is detected, underline the possibility of variable radiographic presentation and the significance of a multidisciplinary approach in correct diagnosis and treatment. Histological subtyping is crucial for guiding treatment.